Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Socioeconomic support reduces nonretention in a comprehensive, community-based antiretroviral therapy program in Uganda.

Talisuna-Alamo S, Colebunders R, Ouma J, Sunday P, Ekoru K, Laga M, Wagner G, Wabwire-Mangen F.

J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):e52-9. doi: 10.1097/QAI.0b013e318246e2aa.

2.

Return to normal life after AIDS as a reason for lost to follow-up in a community-based antiretroviral treatment program.

Alamo ST, Colebunders R, Ouma J, Sunday P, Wagner G, Wabwire-Mangen F, Laga M.

J Acquir Immune Defic Syndr. 2012 Jun 1;60(2):e36-45. doi: 10.1097/FTD.0b013e3182526e6a.

3.

Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.

Schöni-Affolter F, Keiser O, Mwango A, Stringer J, Ledergerber B, Mulenga L, Bucher HC, Westfall AO, Calmy A, Boulle A, Chintu N, Egger M, Chi BH; Swiss HIV Cohort Study; IeDEA Southern Africa.

PLoS One. 2011;6(12):e27919. doi: 10.1371/journal.pone.0027919. Epub 2011 Dec 19.

4.

Community adherence support improves programme retention in children on antiretroviral treatment: a multicentre cohort study in South Africa.

Grimwood A, Fatti G, Mothibi E, Malahlela M, Shea J, Eley B.

J Int AIDS Soc. 2012 May 31;15(2):17381. doi: 10.7448/IAS.15.2.17381.

5.

Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programs.

Grimsrud A, Balkan S, Casas EC, Lujan J, Van Cutsem G, Poulet E, Myer L, Pujades-Rodriguez M.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):e55-66. doi: 10.1097/QAI.0000000000000268.

PMID:
24977472
6.

Cost-effectiveness of socioeconomic support as part of HIV care for the poor in an urban community-based antiretroviral program in Uganda.

Stella-Talisuna A, Bilcke J, Colebunders R, Beutels P.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):e76-83. doi: 10.1097/QAI.0000000000000280.

PMID:
25032486
7.

Four-year retention and risk factors for attrition among members of community ART groups in Tete, Mozambique.

Decroo T, Koole O, Remartinez D, dos Santos N, Dezembro S, Jofrisse M, Rasschaert F, Biot M, Laga M.

Trop Med Int Health. 2014 May;19(5):514-21. doi: 10.1111/tmi.12278. Epub 2014 Feb 12.

8.

Mortality and loss to follow-up in the first year of ART: Malawi national ART programme.

Weigel R, Estill J, Egger M, Harries AD, Makombe S, Tweya H, Jahn A, Keiser O.

AIDS. 2012 Jan 28;26(3):365-73. doi: 10.1097/QAD.0b013e32834ed814.

9.

Antiretroviral treatment for HIV in rural Uganda: two-year treatment outcomes of a prospective health centre/community-based and hospital-based cohort.

Kipp W, Konde-Lule J, Saunders LD, Alibhai A, Houston S, Rubaale T, Senthilselvan A, Okech-Ojony J.

PLoS One. 2012;7(7):e40902. doi: 10.1371/journal.pone.0040902. Epub 2012 Jul 17.

10.

Two-year death and loss to follow-up outcomes by source of referral to HIV care for HIV-infected patients initiating antiretroviral therapy in rural Mozambique.

Blevins M, José E, Bilhete FR, Vaz LM, Shepherd BE, Audet CM, Vermund SH, Moon TD.

AIDS Res Hum Retroviruses. 2015 Feb;31(2):198-207. doi: 10.1089/AID.2014.0007. Epub 2014 Dec 17.

11.

Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda.

Abaasa AM, Todd J, Ekoru K, Kalyango JN, Levin J, Odeke E, Karamagi CA.

BMC Health Serv Res. 2008 Nov 20;8:241. doi: 10.1186/1472-6963-8-241.

12.

Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.

Verguet S, Lim SS, Murray CJ, Gakidou E, Salomon JA.

J Infect Dis. 2013 Jan 1;207(1):72-9. doi: 10.1093/infdis/jis635. Epub 2012 Oct 24.

13.

Patients' demographic and clinical characteristics and level of care associated with lost to follow-up and mortality in adult patients on first-line ART in Nigerian hospitals.

Odafe S, Idoko O, Badru T, Aiyenigba B, Suzuki C, Khamofu H, Onyekwena O, Okechukwu E, Torpey K, Chabikuli ON.

J Int AIDS Soc. 2012 Sep 18;15(2):17424. doi: 10.7448/IAS.15.2.17424.

14.

Illicit drug use is a significant risk factor for loss to follow up in patients with HIV-1 infection at a large urban HIV clinic in Tokyo.

Nishijima T, Gatanaga H, Komatsu H, Takano M, Ogane M, Ikeda K, Oka S.

PLoS One. 2013 Aug 7;8(8):e72310. doi: 10.1371/journal.pone.0072310. eCollection 2013.

15.

Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.

Tweya H, Feldacker C, Estill J, Jahn A, Ng'ambi W, Ben-Smith A, Keiser O, Bokosi M, Egger M, Speight C, Gumulira J, Phiri S.

PLoS One. 2013 Sep 26;8(9):e75761. doi: 10.1371/journal.pone.0075761. eCollection 2013.

16.

Patients who return to care after tracking remain at high risk of attrition: experience from a large HIV clinic, Uganda.

Nakiwogga-Muwanga A, Musaazi J, Katabira E, Worodria W, Talisuna SA, Colebunders R.

Int J STD AIDS. 2015 Jan;26(1):42-7. doi: 10.1177/0956462414529098. Epub 2014 Mar 19.

PMID:
24648320
17.

Male gender predicts mortality in a large cohort of patients receiving antiretroviral therapy in Uganda.

Mills EJ, Bakanda C, Birungi J, Chan K, Hogg RS, Ford N, Nachega JB, Cooper CL.

J Int AIDS Soc. 2011 Nov 3;14:52. doi: 10.1186/1758-2652-14-52.

18.

Task-shifting to community health workers: evaluation of the performance of a peer-led model in an antiretroviral program in Uganda.

Alamo S, Wabwire-Mangen F, Kenneth E, Sunday P, Laga M, Colebunders RL.

AIDS Patient Care STDS. 2012 Feb;26(2):101-7. doi: 10.1089/apc.2011.0279. Epub 2012 Jan 6.

PMID:
22224411
19.

Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda.

Bakanda C, Birungi J, Mwesigwa R, Nachega JB, Chan K, Palmer A, Ford N, Mills EJ.

PLoS One. 2011 Apr 29;6(4):e19261. doi: 10.1371/journal.pone.0019261.

20.

Mortality among adults transferred and lost to follow-up from antiretroviral therapy programmes in South Africa: a multicenter cohort study.

Cornell M, Lessells R, Fox MP, Garone DB, Giddy J, Fenner L, Myer L, Boulle A; IeDEA-Southern Africa Collaboration.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):e67-75. doi: 10.1097/QAI.0000000000000269.

Items per page

Supplemental Content

Write to the Help Desk